Dawn Watkins, MD
Family Medicine · Hurley, MSNPI 1912967795
Payments from drug & device makers
Across 605 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$1K
- AbbVie$918
- GSK$673
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 92 | $1,450 |
| AstraZeneca | 64 | $1,385 |
| Novo Nordisk | 84 | $1,318 |
| Boehringer Ingelheim | 68 | $1,187 |
| AbbVie(2 entities) | 51 | $918 |
| GSK | 52 | $673 |
| Bayer | 29 | $600 |
| Renalytix AI, Inc. | 18 | $507 |
| Abbott | 34 | $485 |
| Amgen | 17 | $397 |
| Pfizer | 10 | $265 |
| Daiichi Sankyo Inc. | 9 | $172 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $127 |
| Exact Sciences | 7 | $105 |
| Johnson & Johnson | 7 | $93 |
| Astellas Pharma US Inc | 6 | $92 |
| Kowa Pharmaceuticals America, Inc. | 6 | $89 |
| GRT US Holding, Inc. | 1 | $87 |
| Merck | 6 | $87 |
| Novartis | 7 | $86 |
| Corcept Therapeutics | 5 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Averitas Pharma Inc. | 2 | $51 |
| Radius Health, Inc. | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Genentech USA, Inc. | 2 | $24 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Medtronic | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Biogen | 1 | $15 |
How this compares
$10,601 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Hurley
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.